Vacuolar Leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2

被引:94
作者
Hubbs, Ann F.
Benkovic, Stanley A.
Miller, Diane B.
C'Callaghan, James P.
Battelli, Lori
Schwegler-Berry, Diane
Ma, Qiang
机构
[1] NIOSH, Receptor Biol Lab, Toxicol & Mol Biol Branch, Hlth Effects Lab Div,Ctr Dis Control & Prevent, Morgantown, WV 26505 USA
[2] NIOSH, Expt Pathol Lab, Pathol & Physiol Res Branch, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA
[3] NIOSH, Chron Stress & Neurotoxicol Lab, Morgantown, WV 26505 USA
[4] NIOSH, Mol Neurotoxicol Lab, Morgantown, WV 26505 USA
关键词
D O I
10.2353/ajpath.2007.060898
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
NFE2-related factor 2 (Nrf2), an oxidant-activated CNC bZip transcription factor, has been implicated in defense against oxidative stress and chemical insults in a range of cell and tissue types, including the central nervous system. Here, we report that deletion of the Nrf2 gene in mice caused vacuolar (spongiform) leukoencephalopathy with widespread astrogliosis. The leukoencephalopathy was present in all Nrf2-null mice more than 10 months of age, was characterized by vacuolar degeneration involving all major brain regions, and was most apparent in the white tracts of the cerebellum and pons. Vacuolar degeneration in white tracts was attributable to myelin unwinding and intramyelinic cysts, and double-label immunofluorescence for 4-hydroxy-2-nonenal and myelin basic protein localized free-radical induced oxidative damage to the myelin sheath. Moreover, the brains of Nrf2-null mice exhibited widespread astrocyte activation with profusion of glial fibrillary acidic protein-immunoreactive glial processes. The study uncovered a possible physiological role for Nrf2 in maintaining central nervous system myelin. if this role is confirmed, it may suggest new approaches to treating genetically and chemically induced myelin degenerative diseases.
引用
收藏
页码:2068 / 2076
页数:9
相关论文
共 33 条
[1]  
[Anonymous], 1999, PATHOLOGY MOUSE REFE
[2]   Sensitive indicators of injury reveal hippocampal damage in C57BL/6J mice treated with kainic acid in the absence of tonic-clonic seizures [J].
Benkovic, SA ;
O'Callaghan, JP ;
Miller, DB .
BRAIN RESEARCH, 2004, 1024 (1-2) :59-76
[3]   Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment [J].
Berger, J ;
Moser, HW ;
Forss-Petter, S .
CURRENT OPINION IN NEUROLOGY, 2001, 14 (03) :305-312
[4]   IMMUNOCYTOCHEMICAL STAINING OF ASTROCYTES, TANYCYTES, IMMATURE GLIAL-CELLS AND EPENDYMAL CELLS IN THE CENTRAL NERVOUS-SYSTEM OF THE NORMAL RAT AND THE MYELIN-DEFICIENT MUTANT [J].
CAMMER, W ;
TANSEY, FA .
DEVELOPMENTAL NEUROSCIENCE, 1989, 11 (02) :90-98
[5]   REACTIVE GLIAL-CELLS IN CNS DEMYELINATION CONTAIN BOTH GC AND GFAP [J].
CARROLL, WM ;
JENNINGS, AR ;
MASTAGLIA, FL .
BRAIN RESEARCH, 1987, 411 (02) :364-369
[6]   NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development [J].
Chan, KM ;
Lu, RH ;
Chang, JC ;
Kan, YW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13943-13948
[7]   An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen [J].
Chan, KM ;
Han, XD ;
Kan, YW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) :4611-4616
[8]   Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000) [J].
Eng, LF ;
Ghirnikar, RS ;
Lee, YL .
NEUROCHEMICAL RESEARCH, 2000, 25 (9-10) :1439-1451
[9]   GFAP AND ASTROGLIOSIS [J].
ENG, LF ;
GHIRNIKAR, RS .
BRAIN PATHOLOGY, 1994, 4 (03) :229-237
[10]   RUMPSHAKER - AN X-LINKED MUTATION CAUSING HYPOMYELINATION - DEVELOPMENTAL DIFFERENCES IN MYELINATION AND GLIAL-CELLS BETWEEN THE OPTIC-NERVE AND SPINAL-CORD [J].
FANARRAGA, ML ;
GRIFFITHS, IR ;
MCCULLOCH, MC ;
BARRIE, JA ;
KENNEDY, PGE ;
BROPHY, PJ .
GLIA, 1992, 5 (03) :161-170